Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

VRCA Stock Forecast, Price Targets, Chart, Dividends & Analysis

Verrica Pharmaceuticals Inc. logo

Verrica Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

0.69
 
USD
  
0.02
  
(2.65%)
Previous close: 0.6763  Open: 0.6801  Bid: 0.6603  Ask: 0.703
52 week range    
0.61   
   11.41
Mkt Cap: 32 M  Avg Vol (90 Days): 889,833
Peers   
OMHE / 
OILS-CA / 
OGN / 
Last updated: Sunday 22nd December 2024

Stock Rankings

42
MarketXLS Rank
60
Value
46
Technical
21
Quality
How are these ranks calculated?
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

OGN

0.07684 B2.8914.58

OILS-CA

OMHE

ONPH

Financials

VRCA Income Statement

Annual
Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-1.71-1.3-0.72-1.48
Basic EPS total-1.71-1.3-0.72-1.48
Basic weighted shares outstanding15 M25 M25 M27 M34 M45 M
Cost of sales725000.0746000.0
Depreciation-20300.0-64200.043000.0244000.0500000.0500000.0
DepreciationAndAmortization-20300.0-64200.043000.0244000.0500000.0500000.0
Diluted EPS total-1.41-1.13-1.71-1.3-0.72-1.48
Diluted normalized net income/share-1.13-0.72-1.48
Diluted weighted shares outstanding15 M25 M25 M27 M34 M45 M
GainOnSaleOfPPE-3 M
GeneralAndAdministrativeExpense9 M15 M25 M27 M17 M47 M
Gross operating profit12 M8 M4 M
Income before tax-21 M-28 M-43 M-35 M-24 M-67 M
Income taxes-3 M-3 M-955000.0-2 M
Interest income1 M2 M521000.0123000.0476000.03 M
InterestExpenseNonOperating3 M4 M2 M4 M
MiscOtherSpecialCharges-1 M-14000.0
Net income from total operations-21 M-28 M-43 M-35 M-24 M-67 M
NetIncomeCommonStockholders-21 M-28 M-43 M-35 M-24 M-67 M
NetIncomeContinuousOperations-21 M-28 M-43 M-35 M-24 M-67 M
NetNonOperatingInterestIncomeExpense1 M2 M-3 M-4 M-2 M-1 M
Normalized income-38 M
Operating income-22 M-30 M-40 M-31 M-21 M-66 M
Operating income before depreciation (EBITDA)-21 M-29 M-39 M-30 M-22 M-62 M
OperatingExpense-22 M30 M40 M43 M30 M71 M
Other income net-1 M-3 M
OtherGandA9 M15 M25 M27 M17 M47 M
OtherImpairmentOfCapitalAssets3 M
OtherOperatingExpenses1000.04000.0186000.0367000.0-725000.0-746000.0
PromotionAndAdvertising4 M
RentAndLandingFees9 M-228000.0186000.0
Research & development expense13 M15 M16 M16 M12 M20 M
ResearchExpense13 M15 M16 M16 M12 M20 M
Revenue per share-435000.05000.04000.020000.0
SalariesAndWages-2 M-3 M
Selling Gen & administrative expense9 M15 M25 M27 M17 M47 M
SellingAndMarketingExpense4 M
Total Income available for interest expense (EBIT)-21 M-28 M-40 M-31 M-22 M-63 M
Total common shares outstanding26 M26 M25 M28 M42 M42 M
Total net income-21 M-28 M-43 M-35 M-24 M-67 M
Total ordinary shares46 M46 M46 M46 M46 M46 M
Total revenues12 M9 M5 M
TotalExpenses-22 M30 M40 M43 M30 M68 M
TotalRevenue12 M9 M5 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University